SARS-CoV-2 vaccines

RNA replicons encoding coronavirus S proteins, in particular SARS-CoV-2 S proteins, are described. Also described are pharmaceutical compositions and uses of the RNA replicons.

Saved in:
Bibliographic Details
Main Authors VIJAYAN, Aneesh, VAN DER NEUT KOLFSCHOTEN, Marijn, VOGELS, Ronald, DEHART, Jason, BAKKERS, Mark Johannes Gerardus, RUTTEN, Lucy, MARRO, Brett Steven, LANGEDIJK, Johannes Petrus Maria, MAINE, Christian
Format Patent
LanguageEnglish
Published 02.02.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:RNA replicons encoding coronavirus S proteins, in particular SARS-CoV-2 S proteins, are described. Also described are pharmaceutical compositions and uses of the RNA replicons.
Bibliography:Application Number: AU20210272741